Oncology Institute Inc (TOI) Key Ratios

$6.20

up-down-arrow $1.17 (23.26%)

As on 11-Aug-2026 09:30EDT

Market cap

info icon

$513 Mln

Revenue (TTM)

info icon

$546 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

0.8

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 3.86 41.22 35.37 25.89 23.23
EBIT 90.02 96.02 32.42 2.08 -237.88
Net Profit 66.81 87.28 32.39 3.68 -242.86
EPS 66.92 99.04 94.69 24.51 12.02
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-25Dec-24
EBIT-Margin info -14.31-18.76-6.60-9.84-14.53
Net Margin info ---2.77-7.97----
Return on equity info 231.21135.45--999.19-213.36
Return on Capital info -46.60-30.97---56.45-42.62
Return on Assets info -35.02-22.62-18.47-35.93-33.86
Debt to Equity (x) info -----4.83-6.6034.31
ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Oncology Institute Inc (TOI)
--
-56.45
-42.62
-40.71
0.09
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

--

--

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Oncology Institute Inc (TOI)
--
999.19
-213.36
-92.20
0.13
Peer Median
7.96
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-18.47

Lower than Peers by 20.24

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Oncology Institute Inc (TOI)
-18.47
-35.93
-33.86
-35.28
0.07
Peer Median
1.76
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-6.60

Lower than Peers by 13.19

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Oncology Institute Inc (TOI)
-6.60
-9.84
-14.53
-18.55
-28.52
Peer Median
6.60
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-7.97

Lower than Peers by 10.98

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Oncology Institute Inc (TOI)
-7.97
-12.06
-16.44
-25.62
0.04
Peer Median
3.01
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Oncology Institute Inc (TOI)
0.00
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Revenue Growth

35.37

Higher than Peers by 25.62

Year on year growth in net sales

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Oncology Institute Inc (TOI)
35.37
0.28
0.21
0.28
0.24
Peer Median
9.75
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

32.42

Higher than Peers by 15.43

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Oncology Institute Inc (TOI)
32.42
13.48
4.96
16.47
-58.67
Peer Median
16.99
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

32.39

Higher than Peers by 15.01

Year on year growth in profit after tax

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Oncology Institute Inc (TOI)
32.39
6.27
22.16
-54,750.00
101.39
Peer Median
17.38
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

94.69

Higher than Peers by 78.32

Year on year growth in earnings per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Oncology Institute Inc (TOI)
94.69
0.93
0.24
-637.63
1.01
Peer Median
16.37
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

-124.33

Lower than Peers by 129.69

Year on year growth in book value per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Oncology Institute Inc (TOI)
-124.33
--
--
--
--
Peer Median
5.36
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Debt to Equity

-4.83

Lower than Peers by 5.22

Total debt / Net worth

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Oncology Institute Inc (TOI)
-4.83
-6.60
34.31
2.10
0.88
Peer Median
0.39
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

-0.45

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Oncology Institute Inc (TOI)
-0.45
-0.46
1.89
0.11
0.04
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

1.47

Lower than Peers by 0.05

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Oncology Institute Inc (TOI)
1.47
1.59
2.15
4.12
4.39
Peer Median
1.53
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

1.17

Lower than Peers by 0.25

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Oncology Institute Inc (TOI)
1.17
1.35
1.96
3.73
4.08
Peer Median
1.42
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-4.71

Lower than Peers by 8.15

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Oncology Institute Inc (TOI)
-4.71
-4.39
-7.63
-8.88
-17.64
Peer Median
3.44
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

10.89

Lower than Peers by 2.51

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Oncology Institute Inc (TOI)
10.89
11.80
12.37
13.23
16.01
Peer Median
13.40
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

2.32

Higher than Peers by 1.54

Sales / Average Total Assets

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Oncology Institute Inc (TOI)
2.32
2.98
2.06
1.38
1.09
Peer Median
0.78
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Oncology Institute Inc (TOI)
--
39.23
42.52
46.94
44.61
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Oncology Institute Inc (TOI)
--
11.53
12.76
15.83
14.31
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Oncology Institute Inc (TOI)
--
28.91
20.85
16.42
22.72
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Oncology Institute Inc (TOI)
--
21.85
34.43
46.35
36.20
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Oncology Institute Inc (TOI)
--
-59.60
-0.36
-1.80
929.12
Peer Median
33.16
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

0.76

Lower than Peers by 2.77

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Oncology Institute Inc (TOI)
0.76
-229.76
6.51
2.63
1.15
Peer Median
3.54
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Oncology Institute Inc (TOI)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

8.53

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Oncology Institute Inc (TOI)
8.53
-86.60
-1.90
-3.44
-2.60
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

513

Higher than Peers by 150

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Oncology Institute Inc (TOI)
513
--
--
--
--
Peer Median
363
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...